{
  "ptid_time": "016_S_4887_2012-08-21",
  "img_path": "/data/qiuhui/data/adni/images/016_S_4887/2012-08-21/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 47,165 mm³, 22.5% above the reference mean. With a Z-score of 0.54 (70.5th percentile), this represents normal volume ; whole brain volume measures 998,848 mm³, 7.5% below the reference mean. With a Z-score of -0.97 (16.6th percentile), this represents normal volume . ",
  "text_data": "Age is 73.8 years. Gender is Male. Education: 12 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary. MMSE: 26.0. MoCA: 20.0. Logical Memory: 2.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.63 SUVR (profound elevated); Amyloid beta: 818.30 pg/mL (normal ); Total tau: 216.50 pg/mL (normal ); Phosphorylated tau: 21.33 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows normal brain volumes with slightly reduced whole brain volume (16.6th percentile) but no significant atrophy. The MMSE (26) is borderline normal, while the MoCA (20) suggests mild cognitive impairment. Biomarkers (Aβ, T-tau, P-tau) are normal, but AV45 (amyloid PET) is profoundly elevated, indicating amyloid pathology despite normal CSF markers.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (due to conflicting biomarker findings—normal CSF but elevated AV45—and cognitive scores suggesting MCI but not dementia).",
  "timestamp": "2025-07-26T00:29:53.559317"
}